(Q34955938)

5 August 2017

Intestine may be a major site of action for the apoA-I mimetic peptide 4F whether administered subcutaneously or orally (English)

1 reference

5 August 2017

Mohamad Navab

1

1 reference

5 August 2017

Srinivasa T Reddy

2

1 reference

5 August 2017

G M Anantharamaiah

3

1 reference

5 August 2017

Satoshi Imaizumi

4

1 reference

5 August 2017

Greg Hough

5

1 reference

5 August 2017

Susan Hama

6

1 reference

5 August 2017

Alan M Fogelman

7

1 reference

5 August 2017

28 March 2011

1 reference

Journal of Lipid Research

5 August 2017

1 reference

5 August 2017

52

1 reference

5 August 2017

6

1 reference

5 August 2017

1200-1210

1 reference

Treatment of patients with cardiovascular disease with L-4F, an apo-A1 mimetic, did not improve select biomarkers of HDL function.

5 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3090241

Apolipoprotein A-I (apoA-I) and apoA-I mimetic peptides inhibit tumor development in a mouse model of ovarian cancer

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3090241

4F Peptide reduces nascent atherosclerosis and induces natural antibody production in apolipoprotein E-null mice

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3090241

Apolipoprotein A-I mimetic peptides prevent atherosclerosis development and reduce plaque inflammation in a murine model of diabetes

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3090241

Structure/function relationships of apolipoprotein a-I mimetic peptides: implications for antiatherogenic activities of high-density lipoprotein.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3090241

D-amino acids trigger biofilm disassembly

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3090241

A new HDL mimetic peptide that stimulates cellular cholesterol efflux with high efficiency greatly reduces atherosclerosis in mice

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3090241

A novel method for oral delivery of apolipoprotein mimetic peptides synthesized from all L-amino acids.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3090241

Apolipoprotein A-I mimetic peptide helix number and helix linker influence potentially anti-atherogenic properties

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3090241

Safety, pharmacokinetics, and pharmacodynamics of oral apoA-I mimetic peptide D-4F in high-risk cardiovascular patients

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3090241

Pseudomonas aeruginosa LD-carboxypeptidase, a serine peptidase with a Ser-His-Glu triad and a nucleophilic elbow

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3090241

Apolipoprotein A-I mimetic peptides

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3090241

Turnover of synthetic class A amphipathic peptide analogues of exchangeable apolipoproteins in rats. Correlation with physical properties

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3090241

Oral administration of an Apo A-I mimetic Peptide synthesized from D-amino acids dramatically reduces atherosclerosis in mice independent of plasma cholesterol

8 July 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M013144

Oral D-4F causes formation of pre-beta high-density lipoprotein and improves high-density lipoprotein-mediated cholesterol efflux and reverse cholesterol transport from macrophages in apolipoprotein E-null mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M013144

Lipoprotein inflammatory properties and serum amyloid A levels but not cholesterol levels predict lesion area in cholesterol-fed rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M013144

D-4F and statins synergize to render HDL antiinflammatory in mice and monkeys and cause lesion regression in old apolipoprotein E-null mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M013144

Increase in serum amyloid a evoked by dietary cholesterol is associated with increased atherosclerosis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M013144

Anti-inflammatory apoA-I-mimetic peptides bind oxidized lipids with much higher affinity than human apoA-I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M013144

D-amino acids govern stationary phase cell wall remodeling in bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M013144

Absorption and excretion of undegradable peptides: role of lipid solubility and net charge

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21444758

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1194/JLR.M013144

1 reference

5 August 2017

1 reference

5 August 2017

1 reference